Applications of the genO‑hCTLA‑4 mouse model

Useful applications for researchers working on different biomedical fields, such as immuno-oncologyinflammation and autoimmunity:

  • Assess the efficacy of CTLA-4-targeting therapeutics
    • Perform tumor growth inhibition assays in the context of monotherapies or combotherapies
  • Investigate the mode of action (MoA) of CTLA-4-targeting compounds and understand their therapeutic potential
  • Evaluate the safety and toxicity of compounds
  • The genO‑hCTLA‑4 model supports long-term studies as immunological memory is observed following treatment

Features

  • Expression of different hCTLA-4 isoforms
  • Physiological regulation and expression pattern of the human CTLA-4
  • Preservation of the target-ligand interaction
  • Fully functional mouse immune system
  • Lack of expression of the murine target gene, thus avoiding cross-reactivity
  • The genO‑hCTLA‑4 model is designed to enable the easy generation of a CTLA-4 conditional Knockout mouse for tissue-specific assessment of compounds’ specificity and toxicity

Related resources and publications

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No results

Validation data

Discover related products to

genO-hCTLA‑4

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Immune checkpoint
CTLA-4
Lag3
ICP (multi-target)

genO-hCTLA‑4/hLAG3

The genO‑hCTLA-4/hLAG3 mouse enables the in vivo efficacy assessment and profiling of immuno-oncology agents targeting the human immune checkpoint CTLA-4 and/or LAG3 in fully immunocompetent mice.

Immune checkpoint
CTLA-4
PD-1
ICP (multi-target)

genO-hPD‑1/hCTLA‑4

The genO‑hPD-1/hCTLA-4 mouse enables the in vivo efficacy assessment and profiling of immuno-oncology agents targeting the human immune checkpoint PD-1 and/or CTLA-4 in fully immunocompetent mice.

Preclinical humanized genO‑hCTLA-4 mouse model

Get in touch about

Let us know how we can help